Staphylococcus and Neisseria Tablets in the Treatment of Acute Exacerbations of Chronic Obstructive Pulmonary Disease.
Status:
Recruiting
Trial end date:
2023-08-01
Target enrollment:
Participant gender:
Summary
It is planned to enroll 495 acute exacerbation of chronic obstructive pulmonary disease
patients, and they will be randomly assigned to the high-dose test group, normal dose test
group or control group at a ratio of 1:1:1, with 165 patients in each group. The course of
treatment is 90 days, and the total follow-up time is one year. The purpose of the study is
to evaluate the effectiveness and safety of different doses of bacterial lysates
(Staphylococcus and Neisseria Tablets) in the treatment of acute exacerbation of chronic
obstructive pulmonary disease.